Intermolecular Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 90

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $61.9M

  • Investors
  • 1

Intermolecular General Information

Description

Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.

Contact Information

Formerly Known As
The BEP Group
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3011 North First Street
  • San Jose, CA 95134
  • United States
+1 (408)
Primary Industry
General Purpose Semiconductors
Acquirer
Vertical(s)
TMT
Corporate Office
  • 3011 North First Street
  • San Jose, CA 95134
  • United States
+1 (408)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intermolecular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 20-Sep-2019 $61.9M Completed Generating Revenue
6. Grant 31-Dec-2015 Completed Generating Revenue
5. IPO 18-Nov-2011 Completed Generating Revenue
4. Later Stage VC (Series D) 07-Jan-2009 Completed Generating Revenue
3. Later Stage VC (Series C) 20-Sep-2006 Completed Product Development
2. Early Stage VC (Series B) 02-Jun-2005 $10.1M $10.9M Completed Product Development
1. Early Stage VC (Series A) 30-Nov-2004 $800K $800K Completed Product Development
To view Intermolecular’s complete valuation and funding history, request access »

Intermolecular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 22,780,964 $0.001000 $0.04 $0.44 $0.44 1x $0.44 27.91%
Series A 8,399,831 $0.001000 $0.01 $0.1 $0.1 1x $0.1 10.29%
To view Intermolecular’s complete cap table history, request access »

Intermolecular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support mater
General Purpose Semiconductors
San Jose, CA
90 As of 2019

Cheongju, South Korea
 

Espoo, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intermolecular Competitors (7)

One of Intermolecular’s 7 competitors is MagnaChip Semiconductor, a Formerly PE-Backed company based in Cheongju, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MagnaChip Semiconductor Formerly PE-Backed Cheongju, South Korea
Beneq Formerly VC-backed Espoo, Finland
IQE Formerly VC-backed Cardiff, United Kingdom
Quantum Materials Formerly Accelerator/Incubator backed San Marcos, TX
Crocus Nano Electronics Formerly VC-backed Moscow, Russia
You’re viewing 5 of 7 competitors. Get the full list »

Intermolecular Patents

Intermolecular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260209934-A1 Doping control in tmd (transition metal dichalcogenide) films Pending 28-Dec-2022
WO-2024145255-A1 Doping control in tmd (transition metal dichalcogenide) films Inactive 28-Dec-2022
US-20250137141-A1 Selective thermal atomic layer etching Active 23-Jun-2022
EP-4515016-A1 ? ?2?oxide buffer layer to promote tiocrystallinity and increase tio2 refractive index for optical applications Pending 26-May-2022
US-20250297352-A1 Oxide buffer layer to promote ti02 crystallinity and increase ti02 refractive index for optical applications Inactive 26-May-2022 C23C14/0036
To view Intermolecular’s complete patent history, request access »

Intermolecular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intermolecular Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced Technology Materials Corporation Minority
Presidio Partners Venture Capital Minority
Redpoint Ventures Venture Capital Minority
Symyx Technologies Corporation Minority
U.S. Venture Partners Venture Capital Minority
To view Intermolecular’s complete investors history, request access »

Intermolecular ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

14.93 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Intermolecular’s complete esg history, request access »

Intermolecular FAQs

  • When was Intermolecular founded?

    Intermolecular was founded in 2004.

  • Where is Intermolecular headquartered?

    Intermolecular is headquartered in San Jose, CA.

  • What is the size of Intermolecular?

    Intermolecular has 90 total employees.

  • What industry is Intermolecular in?

    Intermolecular’s primary industry is General Purpose Semiconductors.

  • Is Intermolecular a private or public company?

    Intermolecular is a Private company.

  • What is the current valuation of Intermolecular?

    The current valuation of Intermolecular is .

  • What is Intermolecular’s current revenue?

    The current revenue for Intermolecular is .

  • How much funding has Intermolecular raised over time?

    Intermolecular has raised $155M.

  • Who are Intermolecular’s investors?

    Advanced Technology Materials, Presidio Partners, Redpoint Ventures, Symyx Technologies, and U.S. Venture Partners have invested in Intermolecular.

  • Who are Intermolecular’s competitors?

    MagnaChip Semiconductor, Beneq, IQE, Quantum Materials, and Crocus Nano Electronics are some of the 7 competitors of Intermolecular.

  • When was Intermolecular acquired?

    Intermolecular was acquired on 20-Sep-2019.

  • Who acquired Intermolecular?

    Intermolecular was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process